4D pharma plc announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was GBP 231,000 compared to GBP 275,000 a year ago. Net loss was GBP 55.450 million compared to GBP 13.726 million a year ago. Basic loss per share from continuing operations was GBP 0.3497 compared to GBP 0.1406 a year ago.